ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HAE vs TFX // GROSS PROFIT MARGIN

Haemonetics Corporation (NYSE) VS. Teleflex Incorporated (NYSE) • 15-METRIC TALLY: HAE 9 — TFX 4
▲ GROSS PROFIT MARGIN LEADER: HAE
gross-margins
59.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HAE VS. TFX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HAE TFX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 59.00% 56.20% +2.80 HAE /gross-margins <GO>
Return on Invested Capital (ROIC) 8.40% 1.80% +6.60 HAE /roic <GO>
EV/EBITDA & P/E Valuation 32.5x 40.9x -8.40 HAE /valuation <GO>
Free Cash Flow Yield 4.78% -18.00% +22.78 HAE /fcf-yield <GO>
Operating Margin 11.70% 5.90% +5.80 HAE /operating-margins <GO>
Net Profit Margin 0.00% -45.40% +45.40 HAE /net-margins <GO>
Revenue Growth (YoY) -2.00% 17.20% -19.20 TFX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 1.01% -1.01 TFX /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.89 2.12 +1.77 HAE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 4/9 +3.00 HAE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 63.6 70.2 -6.60 TFX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.00 0.98 +0.02 HAE /macro-sensitivity <GO>
Forward P/E Multiple — 27.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.45B $5.99B -$540.9M TFX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HAE REV TFX REV HAE GROSS % TFX GROSS % HAE FCF TFX FCF
FY 2025 $1.33B $1.99B 59.0% 56.2% $260.4M —
FY 2024 $1.36B $1.70B 55.0% 61.0% $142.4M —
FY 2023 $1.31B $1.71B — — $122.8M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HAE // BETA 1.00
TFX // BETA 0.98